Benzinga's Top Initiations

Analysts at Canaccord Genuity initiated coverage on shares of Mast Therapeutics

with a “buy” rating. The target price for Mast Therapeutics is set to $3. Mast Therapeutics' shares closed at $0.45 yesterday. Bank of America initiated coverage on shares of NPS Pharmaceuticals

with a “buy” rating. The target price for NPS Pharmaceuticals is set to $46. NPS Pharmaceuticals' shares closed at $33.39 yesterday. Wunderlich initiated coverage on shares of Regions Financial

with a “buy” rating. The target price for Regions Financial is set to $12. Regions Financial's stock closed at $9.33 yesterday. Analysts at Cowen & Company initiated coverage on shares of Orexigen Therapeutics

with an “outperform” rating. The target price for Orexigen Therapeutics is set to $10. Orexigen Therapeutics' shares closed at $6.06 yesterday.